Aging Latin American Population will Drive Peripheral Vascular Procedure Demand Higher Through the Next Decade

According to a new report entitled Latin American Markets for Peripheral Vascular Devices 2006, the PV device market was valued at nearly $80 million in 2005. Demand for procedures will push this market to revenues of roughly $140 million by 2010.

Waltham, MA (PRWEB) August 21, 2006 -- Millennium Research Group (MRG), the global authority on medical technology market intelligence, reports that growth in the elderly Latin American population, combined with increasing incidences of obesity, diabetes, and end-stage renal disease, will drive the demand for peripheral vascular (PV) procedures higher through the next decade. PV procedure growth in Latin America will be supported by the continued establishment of training centers dedicated to the practice of treating peripheral vascular disease. According to a new report entitled Latin American Markets for Peripheral Vascular Devices 2006, the PV device market was valued at nearly $80 million in 2005. Demand for procedures will push this market to revenues of roughly $140 million by 2010.

The aortic stent graft market was the largest segment of the Latin American PV device market in 2005, generating nearly half of market revenues. Over the next five years, continued adoption of endovascular aortic repair (EVAR), including abdominal aortic aneurysm (AAA) and thoracic EVAR technologies, will spur sustained growth in the aortic stent graft market. Both AAA and thoracic EVAR procedures will grow significantly over the next five years due to increasing physician awareness and the accumulation of clinical evidence supporting the practice of EVAR.

MRG’s Latin American Markets for Peripheral Vascular Devices 2006 report is part of the Global Markets for Peripheral Vascular Devices series, which also includes analysis on the Canadian, European, Japanese, and the US markets. The series covers all key industry competitors, including Medtronic (MDT), Boston Scientific (BSX), Cook, Cordis (JNJ), W.L. Gore, Braile, Nano, B. Braun, C.R. Bard (BCR), Biotronik, Terumo (TRUMF.PK), Abbott Vascular Devices (ABT), Vascutek, EV3 (EVVV) and Angiodynamics (ANGO).

About Aortic Stent Grafts
Aortic aneurysms occur when a weak area of the aorta expands or bulges. This condition poses serious health concerns for patients, including the risk of aortic rupture, which is often lethal. An aortic stent graft, which consists of a stent covered by a polymer graft, is a minimally invasive device for the treatment for aortic aneurysms. For many patients, stent graft technology is an alternative to surgical aortic repair using a surgical graft. The latter procedure is associated with significantly longer recovery times and hospital stays.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResources.com), is a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or
registered trademarks of their respective holders.

Amy Krohn
Millennium Research Group
416-364-7776 x101

###